Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
RBI Cuts Repo Rate to 5.25% as Inflation Cools and Growth Outlook Strengthens
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains 



